Optimize Your Phase I to Commercial Transition - CELL & GENE

Single Cell, Cell therapy

Optimize Your Phase I to Commercial Transition

Contact our experts today

– How a one stop shop ATMP CDMO supports your journey from phase 1 to commercialization?
– Why engaging a large scale CDMO early matters?

Discover how to bridge the gap from discovery to industrial manufacturing

Why engaging a large scale CDMO early matters ?

Avoid a costly second tech transfer and delays
Ensure scalability from the start
Secure regulatory compliance
Align your process with commercial requirements

Les ulis Cell for cure

Real-Life Expertise in Clinical & Commercial Scale Manufacturing

3,000 m² GMP area

1,200 m² GMP manufacturing lines

800 m² Quality control lab

300 m² Process development lab

Ready to discuss how to secure your success? Connect with us!

More about CELLforCURE

Connectivity across Europe, Paris area
48 cleanrooms Grade B / C across 7 independent, customizable GMP manufacturing lines
Facility engineered with Quality by Design principles to ensure safety
90% Quality Control in-house for fast release

<span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span><span data-mce-type="bookmark" style="display: inline-block; width: 0px; overflow: hidden; line-height: 0;" class="mce_SELRES_start"></span>

They trust us

CELLforCURE to manufacture Galapagos’ CAR T-Cell therapy candidates for upcoming trials

CellProthera selects CELLforCURE for Phase 3 GMP manufacturing